Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Curetis Acquires qPCR Platform From Carpegen, Systec for €5M

Curetis Acquires qPCR Platform From Carpegen, Systec for €5M

Dec 13, 2016

NEW YORK (GenomeWeb) – Molecular diagnostics developer Curetis announced today it has acquired the real-time qPCR-based Gyronimo platform from joint owners Carpegen and Systec.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In PCR

  1. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  2. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

  3. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

  4. LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

  5. FDA Relaxes Rules for Flu, RSV Molecular Tests During Coronavirus Health Emergency

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.